My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 180

    1.

    Advances in uterine leiomyoma research: the progesterone hypothesis.

    Rein MS.

    Environ Health Perspect. 2000 Oct;108 Suppl 5:791-3. Review.PMID: 11035984 [PubMed - indexed for MEDLINE]Related articles

    2.

    Progesterone: a critical role in the pathogenesis of uterine myomas.

    Rein MS, Barbieri RL, Friedman AJ.

    Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):14-8. Review.PMID: 7847524 [PubMed - indexed for MEDLINE]Related articles

    3.

    Progestins and uterine leiomyoma.

    Schweppe KW.

    Gynecol Endocrinol. 1999 Jun;13 Suppl 4:21-4. Review.PMID: 12227898 [PubMed - indexed for MEDLINE]Related articles

    4.

    Growth factors and cytokines in uterine leiomyomas.

    Andersen J.

    Semin Reprod Endocrinol. 1996 Aug;14(3):269-82. Review.PMID: 8885057 [PubMed - indexed for MEDLINE]Related articles

    5.

    New concepts in the treatment of uterine leiomyomas.

    Stewart EA, Nowak RA.

    Obstet Gynecol. 1998 Oct;92(4 Pt 1):624-7.PMID: 9764641 [PubMed - indexed for MEDLINE]Related articles

    6.

    Etiology, symptomatology, and diagnosis of uterine myomas.

    Parker WH.

    Fertil Steril. 2007 Apr;87(4):725-36. Review.PMID: 17430732 [PubMed - indexed for MEDLINE]Related articles

    7.

    Sex steroidal regulation of uterine leiomyoma growth and apoptosis.

    Maruo T, Ohara N, Wang J, Matsuo H.

    Hum Reprod Update. 2004 May-Jun;10(3):207-20. Review.PMID: 15140868 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells.

    Hodges LC, Houston KD, Hunter DS, Fuchs-Young R, Zhang Z, Wineker RC, Walker CL.

    Mol Cell Endocrinol. 2002 Oct 31;196(1-2):11-20.PMID: 12385821 [PubMed - indexed for MEDLINE]Related articles

    9.

    Etiology and pathogenesis of uterine leiomyomas: a review.

    Flake GP, Andersen J, Dixon D.

    Environ Health Perspect. 2003 Jun;111(8):1037-54. Review.PMID: 12826476 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Drug treatments for uterine fibroma: rationale]

    Fernandez H, Azoulay C, Rostoker G; Agence Française de Sécurité Sanitaire des Produits de Santé.

    J Gynecol Obstet Biol Reprod (Paris). 2005 Jun;34(4):360-405. French. No abstract available. PMID: 16136663 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pathophysiology of uterine leiomyomas.

    Koutsilieris M.

    Biochem Cell Biol. 1992 May;70(5):273-8. Review.PMID: 1323302 [PubMed - indexed for MEDLINE]Related articles

    12.

    Factors in fibroid growth.

    Andersen J.

    Baillieres Clin Obstet Gynaecol. 1998 Jun;12(2):225-43. Review.PMID: 10023420 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Uterine leiomyoma: pathogenesis and treatment]

    Fujii S.

    Nippon Sanka Fujinka Gakkai Zasshi. 1992 Aug;44(8):994-9. Japanese. PMID: 1402231 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of progesterone on growth factor expression in human uterine leiomyoma.

    Maruo T, Matsuo H, Shimomura Y, Kurachi O, Gao Z, Nakago S, Yamada T, Chen W, Wang J.

    Steroids. 2003 Nov;68(10-13):817-24. Review.PMID: 14667973 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ethnic variation in estrogen and progesterone receptor concentration in leiomyoma and normal myometrium.

    Sadan O, van Iddekinge B, Savage N, Robinson M, Zakut H.

    Gynecol Endocrinol. 1988 Dec;2(4):275-82.PMID: 3232551 [PubMed - indexed for MEDLINE]Related articles

    16.

    Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat.

    Burroughs KD, Fuchs-Young R, Davis B, Walker CL.

    Biol Reprod. 2000 Nov;63(5):1322-30.PMID: 11058535 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Uterine fibroids: the elephant in the room.

    Walker CL, Stewart EA.

    Science. 2005 Jun 10;308(5728):1589-92. Review.PMID: 15947177 [PubMed - indexed for MEDLINE]Related articles

    18.

    Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells.

    Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, Ishikawa H, Xue Q, Reierstad S, Innes J, Thung S, Kim JJ, Xu E, Bulun SE.

    J Clin Endocrinol Metab. 2007 Nov;92(11):4459-66. Epub 2007 Sep 4.PMID: 17785366 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.

    van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA.

    Gynecol Endocrinol. 2001 Dec;15 Suppl 6:61-8.PMID: 12227888 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.

    Maruo T, Ohara N, Matsuo H, Xu Q, Chen W, Sitruk-Ware R, Johansson ED.

    Contraception. 2007 Jun;75(6 Suppl):S99-103. Epub 2007 Mar 21. Review.PMID: 17531625 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity